Previous 10 | Next 10 |
CAI International (CAI) +46% on merger deal with Mitsubishi HC Capital.Sykes Enterprises (SYKE) +30% on being acquired by Sitel group for $54.0 per share.AnPac Bio-Medical Science (ANPC) +22% after securing first disease treatment patent in U.S.Geron Corporation (GERN) +20% ...
Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement for Previously Announced Merger Declared Effective by SEC Special Stockholders Meeting Scheduled for July 6, 2021 to Vote on Proposed Merger Merger Expected to Close During Third Quarter of 2...
Gainers: Galectin Therapeutics (GALT) +17%, NexImmune (NEXI) +16%, Kymera Therapeutics (KYMR) +15%, Nurix Therapeutics (NRIX) +15%, DBV Technologies (DBVT) +13%.Losers: LifeMD (LFMD) -24%, CorMedix (CRMD) -11%, Cleveland BioLabs (CBLI) -9...
The substantially improved pharmacological profile of GP532 opens new opportunities for broader therapeutic applications of this class of pharmaceuticals BUFFALO, NY / ACCESSWIRE / April 14, 2021 / Genome Protection, Inc. (GPI), a joint venture between Cleveland BioLabs, Inc. (NASDAQ:CB...
BUFFALO, NY / ACCESSWIRE / February 23, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has closed its previously announced registered direct offering for the issuance and sale of 2,000,000 shares of its common stock at a purchase price of $7.00 per share. H.C. Wainwri...
Cleveland BioLabs ([[CBLI]] -24.6%) entered into definitive agreements with certain healthcare-focused and institutional investors for the issuance and sale of 2M shares at $7/share in a registered direct offering.Gross proceeds expected to be ~$14M; net proceeds to be used for general corpor...
BUFFALO, NY / ACCESSWIRE / February 19, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has entered into definitive agreements with certain healthcare-focused and institutional investors for the issuance and sale of 2,000,000 shares of its common stock at a purchase pri...
Gainers: Vaccinex (VCNX) +106%.Evolus (EOLS) +75%.Energous (WATT) +45%.Viomi Technology (VIOT) +44%.Casa Systems (CASA) +42%.Canaan (CAN) +40%.JMP Group (JMP) +39%.Renren (RENN) +37%.The9 (NCTY) +32%.Forest Road Acquisition (FRX) +26%.Losers: China SXT Pharmaceuticals (SXT...
Puhui Wealth Investment Management (PHCF) -11%.Cleveland BioLabs (CBLI) -11%.Motus GI Holdings (MOTS) -10%.Conduent (CNDT) -9% on Q4 earnings.Aspen Aerogels (ASPN) -9% on Q4 earnings.Onconova Therapeutics (ONTX) -9%.Barnwell Industries (BRN) -6%.Skillful Craftsman Edu...
Greenland Technologies Holding Corporation (GTEC) +186% on signing co-operation agreement with SOCMA.Immunome (IMNM) +152% on discovery of antibodies neutralizing SARS-CoV-2 variants.Avinger (AVGR) +57%.Heritage Global (HGBL) +42%.U.S. Well Services (USWS) +35%.Cleveland BioLabs (CB...
News, Short Squeeze, Breakout and More Instantly...
Cleveland BioLabs Inc. Company Name:
CBLI Stock Symbol:
NASDAQ Market:
Cleveland BioLabs Inc. Website:
Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc." New Corporate Name and Updated Stock Ticker Symbol to Showcase Company's Post-Merger Transformation and Focus on Restoring Immune Health PR Newswire FORT COLLINS, Colo. , Aug. 31...
Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast Audio archive for the event may be accessed from the "Investors" section of the Cytocom website PR Newswire FORT COLLINS, Colo. , Aug. 16, 2021 /PRNewswire/ -- ...
Cytocom, Inc. Reports Second Quarter 2021 Financial Results -All-stock merger transaction between legacy Cleveland BioLabs and legacy Cytocom recently completed; Cytocom, Inc. common stock trading on Nasdaq as "CBLI"- -Well financed allowing multiple clinical programs that c...